Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...